Source:http://linkedlifedata.com/resource/pubmed/id/21168624
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
10
|
| pubmed:dateCreated |
2010-12-20
|
| pubmed:abstractText |
Since previous in vitro studies suspected the metabolite mycophenolate acyl-glucuronide (AcMPAG) to be responsible for the gastrointestinal side effects, we examined the correlation between AcMPAG blood levels and patient gastrointestinal satisfaction inquiries using a standardized, validated questionnaire.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
1873-2623
|
| pubmed:author | |
| pubmed:copyrightInfo |
Copyright © 2010 Elsevier Inc. All rights reserved.
|
| pubmed:issnType |
Electronic
|
| pubmed:volume |
42
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
4049-52
|
| pubmed:meshHeading |
pubmed-meshheading:21168624-Area Under Curve,
pubmed-meshheading:21168624-Gastrointestinal Tract,
pubmed-meshheading:21168624-Glucuronides,
pubmed-meshheading:21168624-Immunosuppressive Agents,
pubmed-meshheading:21168624-Kidney Transplantation,
pubmed-meshheading:21168624-Mycophenolic Acid,
pubmed-meshheading:21168624-Patient Satisfaction,
pubmed-meshheading:21168624-Prospective Studies,
pubmed-meshheading:21168624-Questionnaires
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Neither mycophenolate acyl-glucuronide levels nor their areas under the curve are responsible for the gastrointestinal side effects in kidney transplant recipients receiving EC-MPA: a prospective trial.
|
| pubmed:affiliation |
Klinikum Rechts der Isar, TU Muenchen, Germany. mail@dr-raggi.de
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Validation Studies
|